Ezetimibe



Indications and Reactions:

Role Indications Reactions
Primary
Hypercholesterolaemia 21.2%
Hyperlipidaemia 18.5%
Acute Coronary Syndrome 14.4%
Blood Cholesterol Increased 13.7%
Hypertension 5.5%
Diabetes Mellitus 2.7%
Product Used For Unknown Indication 2.7%
Angina Pectoris 2.1%
Dyslipidaemia 2.1%
Erectile Dysfunction 2.1%
Gout 2.1%
Infection 2.1%
Psoriasis 2.1%
Atrial Fibrillation 1.4%
Blood Cholesterol 1.4%
Essential Hypertension 1.4%
Osteoporosis Prophylaxis 1.4%
Rheumatoid Arthritis 1.4%
Type Iia Hyperlipidaemia 1.4%
Anxiety 0.7%
Myalgia 18.9%
Rhabdomyolysis 15.1%
Muscular Weakness 7.5%
Neutropenia 7.5%
Blood Creatine Phosphokinase Increased 5.7%
Pain In Extremity 3.8%
Pancreatitis Acute 3.8%
Pulmonary Embolism 3.8%
Rash 3.8%
Renal Failure Acute 3.8%
Thrombocytopenia 3.8%
Tremor 3.8%
Vitreous Detachment 3.8%
Vomiting 3.8%
Abdominal Pain 1.9%
Acute Coronary Syndrome 1.9%
Alopecia 1.9%
Alopecia Totalis 1.9%
Aspartate Aminotransferase Increased 1.9%
Blood Creatinine Increased 1.9%
Secondary
Product Used For Unknown Indication 24.8%
Drug Use For Unknown Indication 21.2%
Blood Cholesterol Increased 12.8%
Hyperlipidaemia 11.5%
Hypercholesterolaemia 7.3%
Hypertension 5.1%
Lipid Metabolism Disorder 2.2%
Dyslipidaemia 2.0%
Hiv Infection 1.5%
Congestive Cardiomyopathy 1.4%
Antiplatelet Therapy 1.2%
Atrial Fibrillation 1.2%
High Density Lipoprotein Decreased 1.1%
Type 2 Diabetes Mellitus 1.1%
Gout 1.0%
Type Iia Hyperlipidaemia 1.0%
Blood Cholesterol 1.0%
Completed Suicide 0.9%
Epilepsy 0.9%
Angina Pectoris 0.8%
Rhabdomyolysis 14.0%
Completed Suicide 13.1%
Amyotrophic Lateral Sclerosis 7.2%
Ventricular Tachycardia 7.2%
Paraesthesia 6.8%
Sleep Disorder 6.3%
Death 5.0%
Renal Failure Acute 5.0%
Stevens-johnson Syndrome 4.1%
Weight Decreased 4.1%
Depression 3.6%
Thrombocytopenia 3.6%
Dyspnoea Exertional 2.7%
Liver Function Test Abnormal 2.7%
Myalgia 2.7%
Systemic Lupus Erythematosus 2.7%
Liver Disorder 2.3%
Myopathy 2.3%
Pancreatitis Acute 2.3%
Respiratory Arrest 2.3%
Concomitant
Product Used For Unknown Indication 29.4%
Drug Use For Unknown Indication 24.6%
Hypertension 9.5%
Type 2 Diabetes Mellitus 4.2%
Rheumatoid Arthritis 3.6%
Blood Cholesterol Increased 3.6%
Diabetes Mellitus 3.3%
Prophylaxis 2.7%
Hypercholesterolaemia 2.4%
Pain 2.4%
Hiv Infection 2.2%
Hyperlipidaemia 2.0%
Blood Cholesterol 1.6%
Atrial Fibrillation 1.5%
Depression 1.5%
Osteoporosis 1.3%
Multiple Myeloma 1.2%
Thrombosis Prophylaxis 1.0%
Gastrooesophageal Reflux Disease 1.0%
Cardiac Disorder 0.9%
Vomiting 9.7%
Renal Failure Acute 7.3%
Weight Decreased 7.0%
Rhabdomyolysis 6.6%
Hypoglycaemia 5.5%
Tremor 5.5%
Flushing 5.2%
Thrombocytopenia 5.2%
Myocardial Infarction 4.5%
Pain In Extremity 4.5%
Renal Failure 4.5%
Pruritus 4.1%
Urticaria 4.1%
Weight Increased 4.1%
Dyspnoea 3.9%
Malaise 3.9%
Hypotension 3.8%
White Blood Cell Count Decreased 3.8%
Death 3.6%
Myalgia 3.2%
Interacting
Blood Cholesterol Increased 11.1%
Hyperlipidaemia 11.1%
Hypercholesterolaemia 8.9%
Immunosuppression 6.7%
Pain In Extremity 6.7%
Parkinson's Disease 6.7%
Atrial Fibrillation 4.4%
Bipolar I Disorder 4.4%
Cardiovascular Event Prophylaxis 4.4%
Diabetes Mellitus 4.4%
Erectile Dysfunction 4.4%
Hypertension 4.4%
Immunosuppressant Drug Therapy 4.4%
Product Used For Unknown Indication 4.4%
Benign Prostatic Hyperplasia 2.2%
Blood Cholesterol Abnormal 2.2%
Bronchitis 2.2%
Dyslipidaemia 2.2%
Epilepsy 2.2%
Mental Disorder 2.2%
Drug Interaction 18.2%
Pain In Extremity 9.1%
Renal Failure Acute 9.1%
Rhabdomyolysis 9.1%
Vertigo 9.1%
Acidosis 4.5%
Erectile Dysfunction 4.5%
Erythema Nodosum 4.5%
Lipids Abnormal 4.5%
Mobility Decreased 4.5%
Musculoskeletal Stiffness 4.5%
Nephrolithiasis 4.5%
Rectal Haemorrhage 4.5%
Transplant Rejection 4.5%
Vestibular Disorder 4.5%